Heron Therapeutics, Inc.Heron Therapeutics, Inc.Heron Therapeutics, Inc.

Heron Therapeutics, Inc.

No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.02 USD per share, beating the −0.02 USD estimate by 0.00%. Revenue for the same period reached ‪40.59 M‬ USD, despite the estimate of ‪39.87 M‬ USD. For the next quarter, analysts expect −0.01 USD in earnings per share and ‪40.12 M‬ USD in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise